Lipoprotein(a) - the cardiovascular risk factor: significance and therapeutic possibilities

Abstract

About 20 % of the population has raised Lp(a) concentrations and evidence suggests that high levels of Lp(a) are an independent cardivascular risk factor.

Keywords

• alirocumab
• atherosclerosis
• cardiovascular disease
• evolocumab